Tab Application Banner
  • Users Online: 397
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Safety and efficacy of an Anti-CD20 Monoclonal antibody (RedituxTM) In Indian patients with seropositive rheumatoid arthritis

Hegde Arun, Vasdev Vivek, Shanmuganandan Krishnan, Singh Kavita, Kartik Sivasami, Kumar Abhishek

Year : 2018| Volume: 13| Issue : 1 | Page no: 20-25

   This article has been cited by
1 Rituximab biosimilars for lymphoma in Europe
Wojciech Jurczak,Monika Dlugosz Danecka,Christian Buske
Expert Opinion on Biological Therapy. 2019; 19(10): 1045
[Pubmed]  [Google Scholar] [DOI]
2 Rituximab
Reactions Weekly. 2018; 1698(1): 289
[Pubmed]  [Google Scholar] [DOI]
3 Greater access to safe and effective therapeutic options in rheumatoid arthritis
Rajkiran Dudam,Vinod Ravindran
Indian Journal of Rheumatology. 2018; 13(1): 4
[Pubmed]  [Google Scholar] [DOI]


Read this article